The Strength study aim to evaluate the use of the RenalGuard device to protect the patients at high risk to develop acute kidney injury following a complex cardiovascular intervention requiring a high volume of contrast.
- Occurence of contrast-induced nephropathy [ Time Frame: Within 5 days ]
The occurence of contrast-induced nephropathy will be determined:
by an elevation, within 3 days from requiring contrast-procedure, of the serum creatinine (rise of 0.3mg/dl or of 25% compared to basal value) and/or
by the need for dialysis within 5 fays from requiring contrast-procedure
- Full package: submission, monitoring, CEC, statistics, final report.
France & Germany managed by CERC.
11 centers managed by CERC.